A Study of AMG 820 in Subjects With Advanced Solid Tumors

Clinical trial NCT01444404 · COMPLETED

Trial details

NCT number: NCT01444404
Sponsor: AmMax Bio, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignancy Advanced Solid Tumors Cancer Oncology Oncology Patients Tumors

Start date: 2008-03-31
Primary completion: 2014-02-06
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.